IDEX Corporation (IEX) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

IDEX Corporation (IEX) Industrial Operations Profile

IDEX Corporation delivers specialized applied solutions across diverse sectors, including fluid management, health & science, and fire & safety. With a focus on precision engineering and application-specific designs, IDEX serves critical needs in food, pharma, industrial, and public safety markets, maintaining a strong global presence.

What Is the Investment Thesis for IEX?

The company's focus on precision engineering and application-specific solutions drives consistent revenue and earnings growth. With a current P/E ratio of 31.77 and a profit margin of 14.4%, IDEX demonstrates financial strength and profitability. Key catalysts include continued expansion in the health & science sector and strategic acquisitions to broaden its product portfolio. Potential risks include economic downturns affecting industrial spending and increased competition in key markets. The company's dividend yield of 1.31% provides a steady income stream for investors.

Based on FMP financials and quantitative analysis

IEX Key Highlights

Market Cap of $16.4B reflects strong investor confidence in IDEX's market position and growth prospects.

• Profit Margin of 14.4% indicates efficient operations and effective cost management.
• Gross Margin of 44.4% demonstrates the company's ability to command premium pricing and maintain profitability.
• Dividend Yield of 1.31% provides a consistent return to shareholders.
• Beta of 0.98 suggests lower volatility compared to the overall market, making it a relatively stable investment.

Who Are IEX's Competitors?

IEX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are IEX's Key Strengths?

Diversified product portfolio across multiple end markets.

• Strong brand reputation and customer relationships.
• Proven track record of successful acquisitions.
• Experienced management team.

What Are IEX's Weaknesses?

Exposure to cyclical industries.

• Dependence on key suppliers.
• Potential for product liability claims.
• Currency exchange rate fluctuations.

What Could Drive IEX Stock Higher?

Potential acquisitions to expand product lines and market reach in the next 12-18 months.

• Continued growth in the Health & Science Technologies segment due to increasing demand for precision fluidics and optical components.
• Expansion into emerging markets, particularly in Asia-Pacific, driven by industrialization and infrastructure development.

What Are the Key Risks for IEX?

Insider selling — insiders were net sellers of roughly $3.6M recently.

• Economic downturns affecting industrial spending and demand for IDEX's products.
• Increased competition from domestic and international players in key markets.
• Fluctuations in currency exchange rates impacting revenue and profitability.
• Supply chain disruptions affecting the availability and cost of raw materials and components.

What Are the Growth Opportunities for IEX?

• Expansion in the Health & Science Technologies (HST) Segment: The HST segment offers significant growth potential, driven by increasing demand for precision fluidics and optical components in the pharmaceutical, biotechnology, and life sciences industries. IDEX can capitalize on this trend by developing innovative solutions for drug discovery, diagnostics, and medical device manufacturing. The global life science tools market is projected to reach $150 billion by 2028, providing a substantial opportunity for IDEX to expand its market share.
• Strategic Acquisitions to Broaden Product Portfolio: IDEX has a proven track record of successful acquisitions, which can be leveraged to expand its product portfolio and enter new markets. By acquiring companies with complementary technologies and customer bases, IDEX can enhance its competitive position and drive organic growth. The company should focus on acquiring businesses in high-growth areas such as automation, robotics, and advanced materials. This strategy can add 2-5% to annual revenue growth.
• Increasing Demand for Fire & Safety Products: The Fire & Safety/Diversified Products (FSDP) segment benefits from increasing demand for firefighting equipment and rescue tools, driven by urbanization and growing awareness of safety standards. IDEX can capitalize on this trend by developing innovative products that meet the evolving needs of firefighters and emergency responders. The global fire safety equipment market is expected to reach $75 billion by 2027, offering a significant growth opportunity for IDEX.
• Penetration of Emerging Markets: Emerging markets such as China, India, and Brazil offer significant growth opportunities for IDEX, driven by industrialization and infrastructure development. By establishing a local presence and tailoring its products to meet the specific needs of these markets, IDEX can tap into a large and growing customer base. Focus on water treatment and food processing sectors in these regions can yield high returns.
• Leveraging Digital Technologies to Enhance Customer Value: IDEX can leverage digital technologies such as IoT, AI, and cloud computing to enhance its products and services and provide greater value to its customers. By developing smart sensors, predictive maintenance tools, and remote monitoring systems, IDEX can help its customers optimize their operations and reduce downtime. This will lead to increased customer loyalty and recurring revenue streams. Expect a 10-15% increase in customer retention rates.

What Threats Does IEX Face?

• Economic downturns affecting industrial spending.
• Increased competition from domestic and international players.
• Changes in government regulations and safety standards.
• Disruptive technologies.

What Are IEX's Competitive Advantages?

• Specialized product portfolio with application-specific designs.
• Strong brand reputation and customer relationships.
• Extensive distribution network and global reach.
• Proprietary technologies and intellectual property.
• High switching costs for customers due to integration into critical processes.

What Does IEX Do?

IDEX Corporation, founded in 1987 and headquartered in Northbrook, Illinois, has evolved into a global leader in applied solutions. The company operates through three primary segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment provides precision fluid-handling solutions, including pumps, flow meters, and injectors, serving industries such as food, chemical, and energy. The HST segment focuses on precision fluidics, optical components, and laboratory equipment for the food and beverage, pharmaceutical, life sciences, and research markets. The FSDP segment offers firefighting pumps, rescue tools, and engineered banding devices for the fire and rescue industry, as well as dispensing equipment for retail and commercial businesses. IDEX's growth strategy involves organic innovation, strategic acquisitions, and expansion into new markets. The company's commitment to engineering excellence and customer-centric solutions has solidified its position as a trusted partner in various critical industries.

What Products and Services Does IEX Offer?

• Designs and manufactures precision fluidics and flow control systems.
• Produces pumps, flow meters, and injectors for various industries.
• Offers optical components and coatings for scientific and industrial applications.
• Develops and distributes firefighting pumps, rescue tools, and related equipment.
• Provides engineered banding and clamping devices for industrial and commercial use.
• Creates precision equipment for dispensing, metering, and mixing colorants and paints.

How Does IEX Make Money?

• Designs, manufactures, and sells specialized industrial products and solutions.
• Generates revenue through product sales, aftermarket services, and recurring contracts.
• Focuses on high-margin, application-specific solutions for diverse end markets.

What Industry Does IEX Operate In?

IDEX Corporation operates in the industrial machinery sector, which is characterized by steady growth driven by technological advancements and increasing demand for automation and precision solutions. The market is competitive, with key players like ITT Inc. and Nordson Corporation vying for market share. IDEX differentiates itself through its diversified product portfolio and focus on niche applications. The industrial machinery sector is expected to grow at a moderate pace, fueled by infrastructure development and industrial expansion in emerging markets.

Who Are IEX's Key Customers?

• Food and beverage manufacturers
• Pharmaceutical and biotechnology companies
• Fire departments and emergency responders
• Chemical processing plants
• Water and wastewater treatment facilities

Company Profile

IDEX Corporation operates in the Industrial - Machinery industry within the Industrials sector. It is headquartered in Northbrook, US. The company is led by CEO Eric D. Ashleman. IEX has traded publicly since 1989.

Return on equity for IDEX Corporation stands at 12.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.3%, showing how much profit it generates from its asset base. IEX trades at a trailing price-to-earnings ratio of 31.77, above the Industrials sector average of ~28.00x. Its free cash flow yield is 3.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.39 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.0%, the inverse of the P/E and a quick read on earnings relative to price.

IEX Valuation & Market Position

With a $16.4B market cap, IDEX Corporation sits in the large-cap segment of the market. Analyst price targets span from $214.00 to $280.00, with a consensus of $253.89. At the current price of $221.77, that implies approximately 14% upside potential. Relative to its peer group, IEX's quantitative score of 77/100 is above the peer average of 67/100.

Quarterly Financial Performance: IDEX Corporation

Revenue for IDEX Corporation came in at $920.6M during Q2 FY2026, a 3.8% improvement versus the preceding quarter. The company recorded net income of $143.4M, with diluted EPS of $1.93. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Industrials. Across the four most recent quarters, IEX averaged $1.74 in diluted EPS.

IDEX Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 5.37 places it in the safe zone, indicating low near-term bankruptcy risk.

IDEX Corporation has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 5.3% above estimates on average.

Over the past six months, IDEX Corporation insiders filed 15 SEC Form 4 transactions — 6 sales and 9 purchases. On net that is roughly 11K shares disposed (about $3.6M), a signal worth weighing alongside the fundamentals.

IEX Financials

IEX earnings history & estimates →

IEX Latest News

IEX Analyst Consensus

IEX MoonshotScore

IEX Industrials Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources